BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31759166)

  • 41. JAK inhibition in the treatment of diabetic kidney disease.
    Brosius FC; Tuttle KR; Kretzler M
    Diabetologia; 2016 Aug; 59(8):1624-7. PubMed ID: 27333885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of JAK1 Drives Innate Immune Deficiency.
    Witalisz-Siepracka A; Klein K; Prinz D; Leidenfrost N; Schabbauer G; Dohnal A; Sexl V
    Front Immunol; 2018; 9():3108. PubMed ID: 30671064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complete genomic organization and promoter analysis of the round-spotted pufferfish JAK1, JAK2, JAK3, and TYK2 genes.
    Leu JH; Yan SJ; Lee TF; Chou CM; Chen ST; Hwang PP; Chou CK; Huang CJ
    DNA Cell Biol; 2000 Jul; 19(7):431-46. PubMed ID: 10945233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Members of the JAK/STAT proteins are expressed and regulated during development in the mammalian forebrain.
    De-Fraja C; Conti L; Magrassi L; Govoni S; Cattaneo E
    J Neurosci Res; 1998 Nov; 54(3):320-30. PubMed ID: 9819137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diamino-1,2,4-triazole derivatives are selective inhibitors of TYK2 and JAK1 over JAK2 and JAK3.
    Malerich JP; Lam JS; Hart B; Fine RM; Klebansky B; Tanga MJ; D'Andrea A
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7454-7. PubMed ID: 21106455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loss of Tyrosine Kinase 2 Does Not Affect the Severity of
    Yamaji T; Shide K; Kameda T; Sekine M; Kamiunten A; Hidaka T; Kubuki Y; Shimoda H; Abe H; Miike T; Iwakiri H; Tahara Y; Sueta M; Yamamoto S; Hasuike S; Nagata K; Shimoda K
    Anticancer Res; 2017 Jul; 37(7):3841-3847. PubMed ID: 28668884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells.
    Wu M; Wu Y; Lan T; Jiang L; Qian H; Chen Y
    Mol Med Rep; 2016 Aug; 14(2):1849-56. PubMed ID: 27357186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tyk2 mediates effects of urokinase on human vascular smooth muscle cell growth.
    Patecki M; von Schaewen M; Tkachuk S; Jerke U; Dietz R; Dumler I; Kusch A
    Biochem Biophys Res Commun; 2007 Aug; 359(3):679-84. PubMed ID: 17548050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of the beta-catenin gene in the skin of embryonic geese during feather bud development.
    Wu W; Xu RF; Xiao L; Xu H; Gao G
    Poult Sci; 2008 Jan; 87(1):204-11. PubMed ID: 18079472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. JAK2, the JAK2 V617F mutant and cytokine receptors.
    Staerk J; Kallin A; Royer Y; Diaconu CC; Dusa A; Demoulin JB; Vainchenker W; Constantinescu SN
    Pathol Biol (Paris); 2007 Mar; 55(2):88-91. PubMed ID: 16904848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. JAK protein kinase inhibitors.
    Thompson JE
    Drug News Perspect; 2005 Jun; 18(5):305-10. PubMed ID: 16193102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. JAK1/2 inhibition impairs the development and function of inflammatory dendritic epidermal cells in atopic dermatitis.
    Klaeschen AS; Nümm TJ; Herrmann N; Leib N; Maintz L; Sakai T; Wenzel J; Bieber T
    J Allergy Clin Immunol; 2021 Jun; 147(6):2202-2212.e8. PubMed ID: 33338537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23/IL-17 axis.
    Works MG; Yin F; Yin CC; Yiu Y; Shew K; Tran TT; Dunlap N; Lam J; Mitchell T; Reader J; Stein PL; D'Andrea A
    J Immunol; 2014 Oct; 193(7):3278-87. PubMed ID: 25156366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of the janus kinase family increases extracellular signal-regulated kinase 1/2 phosphorylation and causes endoreduplication.
    Reiterer G; Yen A
    Cancer Res; 2006 Sep; 66(18):9083-9. PubMed ID: 16982750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. JAK/STAT signaling in hematological malignancies.
    Vainchenker W; Constantinescu SN
    Oncogene; 2013 May; 32(21):2601-13. PubMed ID: 22869151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of Janus kinase signaling in the pathology of atopic dermatitis.
    Guttman-Yassky E; Irvine AD; Brunner PM; Kim BS; Boguniewicz M; Parmentier J; Platt AM; Kabashima K
    J Allergy Clin Immunol; 2023 Dec; 152(6):1394-1404. PubMed ID: 37536511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Jak2 and Tyk2 are necessary for lineage-specific differentiation, but not for the maintenance of self-renewal of mouse embryonic stem cells.
    Chung BM; Kang HC; Han SY; Heo HS; Lee JJ; Jeon J; Lim JY; Shin I; Hong SH; Cho YS; Kim CG
    Biochem Biophys Res Commun; 2006 Dec; 351(3):682-8. PubMed ID: 17078929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Signal transduction by the atopy-associated human thymic stromal lymphopoietin (TSLP) receptor depends on Janus kinase function.
    Wohlmann A; Sebastian K; Borowski A; Krause S; Friedrich K
    Biol Chem; 2010; 391(2-3):181-186. PubMed ID: 20128689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of Sijunzi decoction and Yupingfeng powder on expression of janus kinase-signal transducer and activator of transcription signal pathway in the brain of spleen-deficiency model rats.
    Xiong B; Qian H
    J Tradit Chin Med; 2013 Feb; 33(1):78-84. PubMed ID: 23596817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic variation in the JAK/STAT/SOCS signaling pathway influences breast cancer-specific mortality through interaction with cigarette smoking and use of aspirin/NSAIDs: the Breast Cancer Health Disparities Study.
    Slattery ML; Lundgreen A; Hines LM; Torres-Mejia G; Wolff RK; Stern MC; John EM
    Breast Cancer Res Treat; 2014 Aug; 147(1):145-58. PubMed ID: 25104439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.